These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12575540)

  • 41. [Changes in the mechanical resistance of red blood cells in dependence on repeated long-term hemodialysis].
    Vacek L; Mocek J
    Vnitr Lek; 1974 Nov; 20(11):1107-10. PubMed ID: 4439665
    [No Abstract]   [Full Text] [Related]  

  • 42. [Case of tetrodotoxin intoxication in a uremic patient].
    Nakashima R; Nakata Y; Kameoka M; Hayashi N; Watanabe K; Yagi K
    Chudoku Kenkyu; 2007 Apr; 20(2):141-5. PubMed ID: 17533966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of extracorporeal hemodialysis on some aspects of hemostatic function in chronic uremia].
    Cocconi G; Ferioli V; Franchini I
    Minerva Nefrol; 1967; 14(4):162-8. PubMed ID: 5304654
    [No Abstract]   [Full Text] [Related]  

  • 44. [Use of hemosorption and hemodialysis in the treatment of chronic renal failure].
    Riabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN
    Ter Arkh; 1981; 53(6):15-21. PubMed ID: 7281026
    [No Abstract]   [Full Text] [Related]  

  • 45. [Assessment of haemostasis in fifteen uraemic patients subjected to chronic haemodialysis (author's transl)].
    Barrantes Boulanger A; Soto Quirós M; Salas González R
    Sangre (Barc); 1980; 25(3):289-99. PubMed ID: 7414445
    [No Abstract]   [Full Text] [Related]  

  • 46. Alteration in red blood cell sodium and potassium concentrations and increased lipid peroxidation in patients with chronic renal failure on maintenance hemodialysis: a hypothesis.
    Paskalev D; Tchankova P; Jankova T; Steiner M; Nenov D
    Am J Nephrol; 1994; 14(3):246-8. PubMed ID: 7832914
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effects of hemosorption and ultraviolet irradiation of blood on morphological properties of erythrocytes in sepsis in the newborn].
    Estrin VV; Murav'ev OV; Komarov AF
    Anesteziol Reanimatol; 1993; (2):40-3. PubMed ID: 7943879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined treatment with hemoperfusion and hemodialysis in patients with chronic uremia.
    Trznadel K; Kidawa Z; Luciak M; Madry K; Lutz W
    Mater Med Pol; 1979; 11(2):167-72. PubMed ID: 513839
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of haemodialysate and its peptide fractions on acetylcholinesterase activity in erythrocytes from healthy subjects and patients with terminal renal failure.
    Smoleński O; Tabarowski Z; Miszta H; Dabrowski Z
    Int Urol Nephrol; 1993; 25(5):503-8. PubMed ID: 8270380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of chronic renal failure and hemodialysis on human red and white cell calmodulin levels.
    Mooradian AD; Morley JE; Levine AS; Ma KW; Korchik W; Beyer HS; Kaiser FE; Brown DM
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1010-3. PubMed ID: 6725505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of erythropoietic activity on red cell parameters in chronic renal failure patients.
    Bovy C; Krzesinski JM; Gothot A; Beguin Y
    Haematologica; 2004 Jun; 89(6):748-9. PubMed ID: 15194543
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 120(6):797-803. PubMed ID: 17391740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chronic bronchitis: participation of red cells in the pathologic process].
    Stepovaia EA; Novitskiĭ VV; Riazantseva NV; Gol'dberg VE; Kolosova MV; Tkachenko SB
    Klin Med (Mosk); 2004; 82(1):53-6. PubMed ID: 15022598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bicarbonate generation and red blood cell (RBC) hypocapnia during acetate hemodialysis (AcHD).
    Bosch J; Constantiner A; Belledonne M; MacMoune F; Glabman S; von Albertini B
    Trans Am Soc Artif Intern Organs; 1981; 27():172-5. PubMed ID: 6800091
    [No Abstract]   [Full Text] [Related]  

  • 55. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients.
    Brunini TM; Roberts NB; Yaqoob MM; Ellory JC; Mann GE; Mendes Ribeiro AC
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):114-8. PubMed ID: 16445709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initial Brazilian experience with short-duration in-center daily hemodialysis.
    Lugon JR; Andre MB
    Hemodial Int; 2005 Jan; 9(1):3-6. PubMed ID: 16191048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dyslipidemia in chronic renal failure patients.
    Almeida AF; Gunjotikar RV; Chitalia V
    J Postgrad Med; 1994; 40(2):52-4. PubMed ID: 8737550
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
    Liu J; Liu ZQ; Tao HQ
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemoperfusion for uremia: past, present, and future.
    Winchester JF; Ash SR
    Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.